151 related articles for article (PubMed ID: 9118037)
21. A prospective, randomised, phase II study of horse antithymocyte globulin vs rabbit antithymocyte globulin as immune-modulating therapy in patients with low-risk myelodysplastic syndromes.
Stadler M; Germing U; Kliche KO; Josten KM; Kuse R; Hofmann WK; Schrezenmeier H; Novotny J; Anders O; Eimermacher H; Verbeek W; Kreipe HH; Heimpel H; Aul C; Ganser A
Leukemia; 2004 Mar; 18(3):460-5. PubMed ID: 14712285
[TBL] [Abstract][Full Text] [Related]
22. Observations on quadruple immunosuppression maintenance therapy using rapamycin, low-dose cyclosporine, mycophenolate mofetil, and prednisone following ATG induction.
Khauli RB; Houjaij A; Sawah S; El-Hout Y; Medawwar W; Hussein M; Habbal A; Daouk M; Uwaydah M; Maacaron H; Abdelnoor A
Transplant Proc; 2005 Sep; 37(7):3031-3. PubMed ID: 16213295
[TBL] [Abstract][Full Text] [Related]
23. The use of selective immunosuppressive therapy on myelodysplastic syndromes in targeted populations results in good response rates and avoids treatment-related disease progression.
Xiao L; Qi Z; Qiusheng C; Li X; Luxi S; Lingyun W
Am J Hematol; 2012 Jan; 87(1):26-31. PubMed ID: 22038646
[TBL] [Abstract][Full Text] [Related]
24. Impact of Thymoglobulin by Stem Cell Source (Peripheral Blood Stem Cell or Bone Marrow) After Myeloablative Stem Cell Transplantation From HLA 10/10-Matched Unrelated Donors: A Report From the Société Française de Greffe de Moelle et de Thérapie Cellulaire.
Ravinet A; Cabrespine A; Socié G; Milpied N; Yakoub Agha I; Nguyen S; Michallet M; Menard AL; Maillard N; Mohty M; Suarez F; Huynh A; Marchand T; Deteix C; Cassuto JP; Maury S; Chevallier P; Reman O; Peffault de Latour R; Bay JO
Transplantation; 2016 Aug; 100(8):1732-9. PubMed ID: 26528768
[TBL] [Abstract][Full Text] [Related]
25. Immunosuppressive therapy for patients with refractory anemia.
Asano Y; Maeda M; Uchida N; Yokoyama T; Osaki K; Shimoda K; Gondo H; Okamura T; Okamura S; Niho Y
Ann Hematol; 2001 Nov; 80(11):634-8. PubMed ID: 11757721
[TBL] [Abstract][Full Text] [Related]
26. Reduced-Intensity Conditioning with Busulfan, Fludarabine, and Antithymocyte Globulin for Hematopoietic Cell Transplantation from Unrelated or Haploidentical Family Donors in Patients with Acute Myeloid Leukemia in Remission.
Lee KH; Lee JH; Lee JH; Kim DY; Park HS; Choi EJ; Ko SH; Seol M; Lee YS; Kang YA; Jeon M; Baek S; Kang YL; Kim SH; Yun SC; Kim H; Jo JC; Choi Y; Joo YD; Lim SN
Biol Blood Marrow Transplant; 2017 Sep; 23(9):1555-1566. PubMed ID: 28552421
[TBL] [Abstract][Full Text] [Related]
27. Anti-thymocyte globulin overcomes the negative impact of HLA mismatching in transplantation from unrelated donors.
Ayuk F; Diyachenko G; Zabelina T; Panse J; Wolschke C; Eiermann T; Binder T; Fehse B; Erttmann R; Kabisch H; Bacher U; Kröger N; Zander AR
Exp Hematol; 2008 Aug; 36(8):1047-54. PubMed ID: 18456390
[TBL] [Abstract][Full Text] [Related]
28. Antithymocyte globulin and cyclosporine A as combination therapy for low-risk non-sideroblastic myelodysplastic syndromes.
Broliden PA; Dahl IM; Hast R; Johansson B; Juvonen E; Kjeldsen L; Porwit-MacDonald A; Sjoo M; Tangen JM; Uggla B; Oberg G; Hellstrom-Lindberg E
Haematologica; 2006 May; 91(5):667-70. PubMed ID: 16670072
[TBL] [Abstract][Full Text] [Related]
29. Successful engraftment without radiation after fludarabine-based regimen in Fanconi anemia patients undergoing genotypically identical donor hematopoietic cell transplantation.
Tan PL; Wagner JE; Auerbach AD; Defor TE; Slungaard A; Macmillan ML
Pediatr Blood Cancer; 2006 May; 46(5):630-6. PubMed ID: 16078221
[TBL] [Abstract][Full Text] [Related]
30. Cyclosporine-responsive thrombocytopenia in a patient with chloramphenicol-associated myelodysplastic syndrome.
Arber C; Buser A; Heim D; Gratwohl A; Tichelli A; Passweg JR
Eur J Haematol; 2006 Mar; 76(3):255-7. PubMed ID: 16451398
[TBL] [Abstract][Full Text] [Related]
31. A pilot study of antithymocyte globulin (ATG) in the treatment of patients with 'low-risk' myelodysplasia.
Killick SB; Mufti G; Cavenagh JD; Mijovic A; Peacock JL; Gordon-Smith EC; Bowen DT; Marsh JC
Br J Haematol; 2003 Feb; 120(4):679-84. PubMed ID: 12588356
[TBL] [Abstract][Full Text] [Related]
32. Hypocellular myelodysplasia.
Sloand EM
Hematol Oncol Clin North Am; 2009 Apr; 23(2):347-60. PubMed ID: 19327588
[TBL] [Abstract][Full Text] [Related]
33. Successful treatment of severe aplastic anemia in children using standardized immunosuppressive therapy with antithymocyte globulin and cyclosporine A.
Goldenberg NA; Graham DK; Liang X; Hays T
Pediatr Blood Cancer; 2004 Dec; 43(7):718-22. PubMed ID: 15390303
[TBL] [Abstract][Full Text] [Related]
34. Clinical effect of reduced-intensity conditioning regimen containing antithymocyte globulin for hematopoietic cell transplantation from unrelated-donors.
Lee KH; Choi SJ; Lee JH; Lee JH; Kim DY; Seol M; Lee YS; Kang YA; Jeon M; Yun SC; Joo YD; Lee WS; Kang MJ; Kim H; Park JH; Bae SH; Ryoo HM; Kim MK; Hyun MS
Am J Hematol; 2011 May; 86(5):399-405. PubMed ID: 21523798
[TBL] [Abstract][Full Text] [Related]
35. [Curative effects of cyclosporin A therapy upon myelodysplastic syndrome].
Chen SC; Jiang B; Da WM; Gong M; Guan M
Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(38):2711-5. PubMed ID: 17199984
[TBL] [Abstract][Full Text] [Related]
36. [Prophylactic effect of CsA, MTX, MMF combined with ATG on GVHD in patients underwent unrelated peripheral blood hematopoietic stem cell transplantation].
Li XH; Gao CJ; Da WM; Yu L; Wu XX; Li HH; Ma J; Cao YB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Apr; 18(2):458-62. PubMed ID: 20416188
[TBL] [Abstract][Full Text] [Related]
37. Antithymocyte globulin improves the survival of patients with myelodysplastic syndrome undergoing HLA-matched unrelated donor and haplo-identical donor transplants.
Wang H; Liu H; Zhou JY; Zhang TT; Jin S; Zhang X; Chen SN; Li WY; Xu Y; Miao M; Wu DP
Sci Rep; 2017 Mar; 7():43488. PubMed ID: 28262717
[TBL] [Abstract][Full Text] [Related]
38. Severe aplastic anaemia--complete response to antilymphocyte globulin and cyclosporin.
Jones-Lecointe A; Murphy A; Charles W; Daisley H; Pitt-Miller P
West Indian Med J; 1999 Dec; 48(4):238-9. PubMed ID: 10639849
[TBL] [Abstract][Full Text] [Related]
39. Relapse of aplastic anemia responsive to sirolimus combined with cyclosporine.
He G; Zhang X; Wu D; Sun A; Wang X
Pediatr Blood Cancer; 2011 Jul; 56(7):1133-5. PubMed ID: 21488160
[TBL] [Abstract][Full Text] [Related]
40. [Myelodysplastic syndrome with der (1;7) transformed from aplastic anemia 42 years after onset].
Kanemura N; Tsurumi H; Hara T; Yamada T; Moriwaki H
Rinsho Ketsueki; 2005 May; 46(5):372-4. PubMed ID: 16444972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]